-
公开(公告)号:JP2005170930A
公开(公告)日:2005-06-30
申请号:JP2004325500
申请日:2004-11-09
Inventor: SUGIYAMA MITSURU , SAKASAI MITSUYOSHI , SHIBUYA YUSUKE , NISHIZAWA YOSHINORI
IPC: A61K8/30 , A61K8/00 , A61K8/64 , A61Q9/04 , A61Q19/00 , A61Q19/08 , C07K9/00 , A61K7/00 , A61K7/155 , A61K7/48
Abstract: PROBLEM TO BE SOLVED: To provide a skin care preparation for external use having efficacy for preventing or improving the aging of skin such as the development of wrinkles and for inhibiting hair growth.
SOLUTION: There is provided fructosyl dipeptide represented by general formula (1): Fru-A-B-R (1) or a salt thereof, and also provided a skin care preparation for external use, a hair growth inhibitor and a wrinkle-preventing or improving agent, each containing the same. In general formula (1), Fru denotes a fructosyl residue; A denotes a valine residue or an isoleucine residue; B denotes a tyrosine residue, a phenylalanine residue, a valine residue or an isoleucine residue; and R denotes a hydroxy group or a methoxy group.
COPYRIGHT: (C)2005,JPO&NCIPIAbstract translation: 要解决的问题:提供一种具有用于预防或改善皮肤老化的效果的外用护肤品,例如皱纹的发展和抑制毛发生长。 提供由通式(1)表示的果糖基二肽:Fru-ABR(1)或其盐,并且还提供用于外用的护肤制剂,毛发生长抑制剂和抗皱纹或 改善剂,每种含量相同。 通式(1)中,Fru表示果糖基残基; A表示缬氨酸残基或异亮氨酸残基; B表示酪氨酸残基,苯丙氨酸残基,缬氨酸残基或异亮氨酸残基; R表示羟基或甲氧基。 版权所有(C)2005,JPO&NCIPI
-
公开(公告)号:JP2002087973A
公开(公告)日:2002-03-27
申请号:JP2000272978
申请日:2000-09-08
Applicant: KAO CORP , OJI PAPER CO
Inventor: HAMA MASAKATSU , ARA KATSUTOSHI , MORI HIROSHI , KOIKE KENZO , TSUCHIKURA TOYOKI , NISHIZAWA YOSHINORI , SAKAINO MAKOTO , KOKUBO RETSUO
IPC: A61K8/00 , A61K8/97 , A61K36/00 , A61K36/18 , A61K36/47 , A61K36/48 , A61K36/60 , A61K36/75 , A61K36/81 , A61P17/00 , A61Q15/00 , A61K35/78 , A61K7/32
Abstract: PROBLEM TO BE SOLVED: To provide a cosmetic capable of persistently suppressing occurrence of unpleasant human body odor. SOLUTION: This cosmetic comprises one or more kinds of leucine dehydrogenase inhibitor not exhibiting antiseptic property to Indigenous bacteria in skin and selected from an extract of a plant selected from Cornus controversa Hemsl., Weigela coraeensis Thunb., Ardisia quinquegona Blume, Syzygium buxifolium Hook.et Arh., Nyssa sylvatica Marsh., Lytbrum salicariaL., Dodonaeaviscosa L., Cyperes alternifolius, Hibiscus glaber, Boninia glabra Planch., Antidesma japonicum S.et Z., Euscaphis japonica Kanitz, Ficus elastica, Tsuga, Ctenitis subglandulosa, Matteuccia struthiopteris L.Todaro, Metaseouoia glvptostroboides Hu et Cheng, Caragana sinica, Stewartia pseudo-camellia Maxim, Callistemon speciosus, Duboisia myoporides R.Br., Lophostemon confertus, Buddlejajaponica Hemsl. and Patrinia scabiosifolia Fisch, and eugenol.
-
公开(公告)号:JP2001354576A
公开(公告)日:2001-12-25
申请号:JP2000171975
申请日:2000-06-08
Applicant: KAO CORP , OJI PAPER CO
Inventor: OGUCHI KENJI , ITO NORIKO , HOTTA MITSUYUKI , NISHIZAWA YOSHINORI , SAKAINO MAKOTO , KOKUBO RETSUO
IPC: A61K8/96 , A61K8/00 , A61K8/97 , A61K36/00 , A61K36/18 , A61P43/00 , A61Q5/00 , A61K35/78 , A61K7/00 , A61K7/06
Abstract: PROBLEM TO BE SOLVED: To provide a hair cosmetic excellent in gray hair growth prevention, gray hair-ameliorating effect and safety as well. SOLUTION: This hair cosmetic as a gray hair-ameliorating agent contains Acer mono or Cycas revoluta or an extract therefrom as the active ingredient.
-
公开(公告)号:JP2000256123A
公开(公告)日:2000-09-19
申请号:JP5553299
申请日:1999-03-03
Applicant: KAO CORP
Inventor: KANAZAWA SATOSHI , NISHIZAWA YOSHINORI , ICHII YUJI , MORI SHINOBU , SATO MAYUMI
IPC: A61K8/96 , A61K8/00 , A61K8/02 , A61K8/97 , A61K36/28 , A61Q19/00 , A61Q19/10 , A61K7/00 , A61K7/48 , A61K7/50 , A61K35/78
Abstract: PROBLEM TO BE SOLVED: To obtain the subject extract which is useful in compositions of preparation for external use for skin or compositions of bath preparation by contacting an extract solvent solution from a thistle group plant with a synthetic adsorbent and removing the adsorbate from the above adsorbent to effect decoloring the extract while holding its lipolytic activity. SOLUTION: This extract is obtained by contacting an extract solvent solution such as ethanol solution from a thistle group plant such as Cirsium nipponicum var incomptum with a synthetic adsorbent, preferably a styrene- divinylbenzene-based synthetic adsorbent, acrylic ester-based synthetic adsorbent or methacrylic acid ester-based synthetic adsorbent, and then removing the adsorbate from the above adsorbent. The amount of the above adsorbent to be used is preferably 0.1-6.0 wt. times based on the solid amount in the solution to be treated. An adsorbent treatment operation is performed preferably under ordinary pressure to 50 atomospheric pressure and at room temperature to 40 deg.C temperature, and in the case of a batch method, the treatment time is preferably 1-24 h.
-
公开(公告)号:JPH1192353A
公开(公告)日:1999-04-06
申请号:JP25502997
申请日:1997-09-19
Applicant: KAO CORP
Inventor: OUCHI ATSUSHI , HOTTA MITSUYUKI , KANAZAWA SATOSHI , NISHIZAWA YOSHINORI , HORI KIMIHIKO
IPC: A61K8/96 , A61K8/00 , A61K8/97 , A61K36/00 , A61K36/18 , A61P3/06 , A61P17/00 , A61Q19/00 , A61K7/48 , A61K7/00 , A61K35/78
Abstract: PROBLEM TO BE SOLVED: To prepare the subject preparation for external use, capable of continuously inhibiting the secretion of sebum on skin or scalp, hardly causing side effects and high in safety by formulating an extract of Echinacea angustifolia and E.purpurea, and/or Tropaeolum majus as an active ingredient. SOLUTION: The objective preparation for external use is obtained by formulating 0.01-10 wt.%, preferably 0.5-5 wt.% extract obtained by carrying out an extraction treatment of pulverized material of root or whole plant of Echinacea angustifolia and E.purpurea, and/or leaf of Tropaeolum majus with one or mixture of two or more kinds of ethanol, propylene glycol, 1,3-butylene glycol and water at 3-70 deg.C, in terms of the dried weight based on the amount of the preparation for the external use as an active ingredient.
-
公开(公告)号:JPH1192339A
公开(公告)日:1999-04-06
申请号:JP25503097
申请日:1997-09-19
Applicant: KAO CORP
Inventor: OUCHI ATSUSHI , HOTTA MITSUYUKI , KANAZAWA SATOSHI , NISHIZAWA YOSHINORI , HORI KIMIHIKO , NISHIJIMA AYUMI
IPC: A61K8/00 , A61K8/97 , A61K36/00 , A61K36/18 , A61P17/00 , A61P43/00 , A61Q5/00 , A61Q7/00 , A61K7/06
Abstract: PROBLEM TO BE SOLVED: To obtain a hair-restoring and growing material, e.g. a lotion and a hair tonic, which shows excellent hair-growing activity against various alopecia in spite of symptoms and individual differences and is safe to the living body by formulating extracts from Echinacea angustifolia, Echinacea purpurea and/or Tropaeolum majus as active ingredients. SOLUTION: This material is obtained by formulating extracts from (A) Echinacea angustifolia, Echinacea purpurea and/or (B) Tropaeolum majus preferably in amounts of 0.01-1 wt.% based on the whole weight in the dry weight. On the above-stated extracts, roots or whole grasses of Echinacea angustifolia or Echinacea purpurea are used as the component A and leaves of Tropaeolum majus are used as the component B. These ground pieces are extracted with a solvent, e.g. an aqueous solution of propylene glycol and the like, preferably at an ordinary temperature of 3-70 deg.C to obtain the material. It is preferable that this hair-restoring and growing agent is used as a solution such as a shampoo and a rinse.
-
公开(公告)号:JPH1112239A
公开(公告)日:1999-01-19
申请号:JP16571897
申请日:1997-06-23
Applicant: KAO CORP
Inventor: SAITO YOSHINORI , KIYOMINE AKIRA , NISHIZAWA YOSHINORI , FUJIKURA YOSHIAKI
IPC: C07C205/26 , C07B61/00 , C07C213/02 , C07C215/68
Abstract: PROBLEM TO BE SOLVED: To produce the subject compound useful as a raw material for dyes, pigments, polymers and agrochemicals by using a 2-halogenophenylacetic acid as a starting raw material. SOLUTION: A 1-(β-hydroxyethyl)-2-halogeno-5-nitrobenzene represented by formula I (X is a halogen) is reacted with benzylamine to provide 1-(β- hydroxyethyl)-2-benzylamino-5-nitrobenzene represented by formula II, which is then reduced to afford the objective compound represented by formula III. The compound represented by formula I is obtained by esterifying a 2- halogenophenylacetic acid represented by formula IV and then nitrating the resultant compound or nitrating the 2-halogenophenylacetic acid and then esterifying the prepared compound, affording a 2-halogeno-5-nitrophenylacetic acid ester and then reducing the resultant ester. The objective compound can be produced in high selectivity and high yield according to a method for passing the inexpensive and readily available compound represented by formula IV as a raw material through the compound represented by formula I which is a new compound.
-
公开(公告)号:JPH10291997A
公开(公告)日:1998-11-04
申请号:JP10303797
申请日:1997-04-21
Applicant: KAO CORP
Inventor: KUSUOKU HIROSHI , NISHIZAWA YOSHINORI , FUJIKURA YOSHIAKI , ICHIKAWA YOSHIAKI , IMOKAWA GENJI
IPC: A61K31/575 , A61P17/00 , A61P37/08 , A61P43/00 , C07J9/00
Abstract: PROBLEM TO BE SOLVED: To obtain a subject novel compound that contains a specific steroid compound, shows an excellent transdermal absorption, stability and safety and is useful as a strongly effective interleukin 4 production inhibitor and as an antiallergic agent that is effective for prevention and treatment of atopic dermatitis. SOLUTION: This is a novel steroid compound represented by formula I (Me is methyl) and is useful as a strongly effective interleukin 4 production inhibitor excellent in transdermal absorption, stability and safety and as an antiallergic agent the has preventive and therapeutic effect on the atopic dermatitis. This steroid compound is obtained by extracting a kind of fungus, Elfvinga (Elfvinga applanta) that has been used as a Chinese medicine. This compound also can be prepared by oxidizing ergosterol of formula II with a selenium dioxide in the presence of methanol to form an isomer followed by treatment of the product with an acid catalyst in methanol to invert the methoxy group in the 3-position thereby giving the objective compound.
-
公开(公告)号:JPH10194919A
公开(公告)日:1998-07-28
申请号:JP1777897
申请日:1997-01-16
Applicant: KAO CORP
Inventor: HORI TAKASHI , NISHIZAWA YOSHINORI , MASUDA MITSUHARU , KAWAKAMI KYOKO
Abstract: PROBLEM TO BE SOLVED: To obtain a skin lotion, excellent in skin-aging-preventing effect and improving effect of skin trouble caused by abnormality of keratinization and having good safety and stability by combinedly using a specific chromone derivative with specific amine derivatives. SOLUTION: This skin lotion is obtained by formulating (A) one or two or more kinds of compound selected from a chromone derivative of formula I (R is a 1-15C straight-chain or branched chain alkyl; R is H, OH or a lower alkoxy) with (B) an amine derivative of formula II (R is a 1-40C alkyl or a 1-40C cycloalkyl; R is H or an alkyl) or its acid additive salt. 2-(1- Ethylpenthyl)-7-methoxychromone, etc., is preferably used as the component A. 1-(2-Hydroxyehylamino)-3-isostearyloxy-2-propanol, etc., is preferably used as the component B. The components A and B are each preferably formulated in a ratio of 0.01-50wt.% and 0.005-10wt.% based on total amount of skin lotion.
-
公开(公告)号:JPH1067656A
公开(公告)日:1998-03-10
申请号:JP32827196
申请日:1996-12-09
Applicant: KAO CORP
Inventor: MURASE TAKATOSHI , HASE TADASHI , SHIBUYA YUSUKE , NISHIZAWA YOSHINORI , TOKIMITSU ICHIROU
IPC: C07D493/04 , A61K31/365 , A61K36/00 , A61P9/10 , A61P31/00 , A61P35/00 , A61P43/00 , A61K35/78
Abstract: PROBLEM TO BE SOLVED: To prepare a medicine, having low cytotoxicity, excellent suppressing actions on cell adhesion and useful as a suppressant, etc., for cancer metastasis by using specific lignans as an active ingredient. SOLUTION: This cell adhesion suppressant comprises lignans represented by the formula (R to R are each H, hydroxyl, an alkyl, a hydroxyalkyl or an alkoxy) as an active ingredient. Furthermore, the lignans are preferably obtained by carrying out the extraction treatment of, e.g. a leaf part of Thujopsis dolabrata Sieb. et Zucc. of the family Cupressaceae with water, an organic solvent such as toluene, an aqueous alcohol, etc., usually at 3-70 deg.C and the lignans are preferably blended in an amount of 1-70wt.% in the pharmaceutical preparation. The dose thereof for an adult is preferably 0.1-2,000mg at a time and daily and perorally administered in one to several portions.
-
-
-
-
-
-
-
-
-